NCT06469307View on ClinicalTrials.gov

Driving Inclusivity, Validity, and Equity in Research Through Strategic Engagement (DIVERSE)

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 9, 2024

Primary Completion Date

July 1, 2026

Study Completion Date

June 30, 2027

Conditions
Blood CancerLeukemia
Interventions
OTHER

DIVERSE Review Process

A participant and community-based review system for clinical research protocols that elicits and collects feedback on investigator-initiated protocol reviews.

Trial Locations (1)

02215

RECRUITING

Dana-Farber Cancer Institute, Boston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

American Society of Clinical Oncology

OTHER

lead

Dana-Farber Cancer Institute

OTHER